172. Hannibal, K. E., & Bishop, M. D. (2014). Chronic stress, cortisol dysfunction, and pain: A psychoneuroendocrine rationale for stress management in pain rehabilitation. Physical Therapy, 94(12), 1816–1825. doi:10.2522/ptj.20130597.
173. Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 865–871. doi:10.1016/S0022-3999(02)00429-4; Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005). A new view on hypocortisolism. Psychoneuroendocrinology, 30(10), 1010–1016. doi:10.1016/j.psyneuen.2005.04.006.
174. Sørensen, C. J., Pedersen, O. B., Petersen, M. S. et al. (2014). Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: Results from the Danish Blood Donor Study (DBDS). PLOS One, 9(2). doi:10.1371/journal.pone.0088196.
175. Williams, W. V. (2017). Hormonal contraception and the development of autoimmunity: A review of the literature. Linacre Quarterly, 84(3), 275–295. doi:10.1080/00243639.2017.1360065.
176. Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008). Sex differences in autoimmune disease from a pathological perspective. American Journal of Pathology, 173(3), 600–609. http://doi.org/10.2353/ajpath.2008.071008.
Глава 8
177. Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51–58. doi:10.1016/s0010-7824(01)00218-9.
178. Gingnell, M., Engman, J., Frick, A. et al. (2013). Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill: A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology, 38(7), 1133–1144. doi:10.1016/j.psyneuen.2012.11.006; Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51-58. doi:10.1016/s0010-7824(01)00218-9; Rosenberg, M. J., & Waugh, M. S. (1998). Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. American Journal of Obstetrics and Gynecology, 179(3), 577–582. doi:10.1016/s0002-9378(98)70047-x; Jarva, J. A., & Oinonen, K. A. (2007). Do oral contraceptives act as mood stabilizers? Evidence of positive affect stabilization. Archives of Women’s Mental Health, 10(5), 225–234. doi:10.1007/s00737-007-0197-5.
179. Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum-Hansen, H. (2011). Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scandinavian Journal of Public Health, 39(Suppl. 7), 12–16. doi:10.1177/1403494811399956.
180. Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum-Hansen, H. (2011). Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scandinavian Journal of Public Health, 39(Suppl. 7), 12–16. doi:10.1177/1403494811399956.
181. Skovlund, C. W., Mørch, L. S., Kessing, L. V., & Lidegaard, Ø. (2016). Association of hormonal contraception with depression. JAMA Psychiatry, 73(11), 1154–1162. doi:10.1001/jamapsychiatry.2016.2387.
182. Toffol, E., Heikinheimo, O., Koponen, P. et al. (2011). Hormonal contraception and mental health: Results of a population-based study. Human Reproduction, 26(11), 3085–3093. doi:10.1093/humrep/der269; Gingnell, M., Engman, J., Frick, A. et al. (2013). Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill: A double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology, 38(7), 1133–1144. doi:10.1016/j.psyneuen.2012.11.006.
183. Skovlund, C. W., Mørch, L. S., Kessing, L. V. et al. (2018). Association of hormonal contraception with suicide attempts and suicides. American Journal of Psychiatry, 175(4), 336–342. doi:10.1176/appi.ajp.2017.17060616.
184. Burke, H., Davis, M. C., Otte, C., & Mohr, D. C. (2005). Depression and cortisol responses to psychosocial stress: A meta-analysis. Psychoneuroendocrinology, 30, 846–856; Burke, H. M., Fernald, L. C., Gertler, P. J., & Adler, N. E. (2005). Depressive symptoms are associated with blunted cortisol stress response in very low income women. Psychosomatic Medicine, 67(6), 211–216.
185. Ayer, L., Greaves-Lord, K., Althoff, R. R. et al. (2013). Blunted HPA axis response to stress is related to a persistent dysregulation profile in youth. Biological Psychology, 93(3), 343–351. doi:10.1016/j.biopsycho.2013.04.002; Aihara, M., Ida, I., Yuuki, N. et al. (2007). HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Research: Neuroimaging, 155(3), 245–256. doi:10.1016/j.pscychresns.2006.11.002; Varghese, F. P., & Brown, E. S. (2001). The hypothalamic-pituitary-adrenal axis in major depressive disorder. Primary Care Companion to the Journal of Clinical Psychiatry, 3(4), 151–155. doi:10.4088/pcc.v03n0401.
186. Krishnakumar, D., Hamblin, M. R., & Lakshmanan, S. (2015). Meditation and yoga can modulate brain mechanisms that affect behavior and anxiety: A modern scientific perspective. Ancient Science, 2(1), 13. doi:10.14259/as.v2i1.171.
